SI Group to Acquire Assets from Albemarle

April 18, 2014
Melanie Sena

Melanie Sena is community editor of Pharmaceutical Technology.

SI Group agrees to purchase certain Albemarle assets and products.

SI Group reported that it has signed a deal to acquire the Antioxidants, Ibuprofen, and related businesses and assets from Albemarle Corporation. The transaction includes manufacturing sites in Orangeburg, South Carolina, andJinshan, China.

The acquisition will include Albemarle’s antioxidant product lines, as well as the Ibuprofen and Propofol businesses. In addition, applications and technical support capabilities in Shanghai and Baton Rouge, Louisiana will be included in the transaction. Subject to the required regulatory approvals, this acquisition is expected to be completed later this year.

Source: SI Group

Related Content:

Industry News